Loading Events
  • This event has passed.

18th Texas Update in Cardiovascular Advancements (Available Via Live Webcast!)

February 9, 2019 | 7:30 am4:00 pm CST

About the Meeting

Online Registration

Live Webcast Registration & Details

Program Overview

Heart and vascular disease are the #1 killers throughout the world for men, women and children. A death from heart or vascular disease occurs every 33 seconds, with 2,600 deaths occurring each day, and more than one million deaths occurring each year. There are 40 million women in the United States presently living with heart or vascular disease. In contrast, there are 8 million women living with cancer in the US presently. A woman is 5 times more likely to die of heart attack than of breast cancer. More women die of heart and vascular disease then of all cancers combined. A young person dies on the playing fields in the US every 2 to 3 weeks. These deaths are almost always caused by underlying but previously unsuspected heart and vascular disease.

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. Our one-day symposium will feature lectures and discussions by distinguished faculty who will provide current information on the status and future directions of cardiovascular medicine and surgery. The faculty will highlight recent progress in the diagnosis and treatment of cardiovascular disease, as well as new therapeutic modalities.

Educational Objectives

At the conclusion of this symposium, participants should be able to –

  • Discuss recent scientific advances in lipid management and the use of statins for acute and chronic coronary artery disease.
  • Recognize the potential therapeutic options with stem cell therapy for cardiovascular disease, including congestive heart failure.
  • Discuss the use of stem cell therapy in the regeneration of damaged heart tissue.
  • Highlight new advances in electrophysiology, including biventricular pacing, defibrillation, and ablation for arrhythmias.
  • Discuss heart disease in women
  • Discuss TAVR to treat valvular aortic stenosis

Target Audience

The audience for this continuing medical education activity includes cardiologists, cardiovascular surgeons, internists, clinical researchers, nurses, technicians, and all interested in cardiovascular disease.


6770 Bertner Avenue

Houston, TX 77030 United States